Yun Kyung Kim,Sung Su Lim,Do Hee Kim,Md. Mamunul Haque,Seul Gi Shin,Ha Eun Lee,Tae Hun Kim,Sang Min Lim,Ae Nim Pae
申请号：
US15697728
公开号：
US09962384B1
申请日:
2017.09.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed is a levosimendan compound, an optically active isomer thereof, or a pharmaceutically acceptable salt thereof, which is used for the prevention and/or treatment of diseases caused by tau aggregation or phosphorylation, such as neurodegenerative diseases (e.g., Alzheimer disease). In accordance with yet another aspect of the present invention, there is provided a health functional food for preventing or treating tau aggregation-related diseases, containing a levosimendan compound or a pharmaceutically acceptable salt, stereoisomer or solvate thereof.
